- Published on
Emergency and Acute Medicine – Bipolar Disorder
Core Concepts And Definitions
Mania has a broad and often subtle presentation that may be difficult to recognize in the emergency setting. Manifestations range from irritability or cheerfulness to agitation, delirium, or frank psychosis, with the full extent of illness often revealed only through collateral history. Onset may be gradual or abrupt, with episodes typically lasting weeks to months and only rarely becoming chronic. Hypomania represents a milder form without marked functional impairment. Mixed mood states involve concurrent manic and depressive features and should be managed as mania in the emergency department. Bipolar disorder, formerly termed manic-depressive illness, is defined by one or more episodes of hypomania, mania, or mixed mood, often accompanied by depressive episodes. Bipolar II disorder refers to patients who experience hypomania but never full mania. The illness commonly begins in adolescence or early adulthood, with episodes varying widely in severity, duration, and frequency. Treatment responsiveness ranges from excellent to highly refractory. Schizoaffective disorder is characterized by mood episodes accompanied by psychotic symptoms that persist even during euthymic periods.
Etiologic Considerations
Bipolar disorder is most often a primary psychiatric illness with a strong genetic association. Secondary causes must be considered, particularly in patients over 40 years of age presenting with a first episode, atypical or mixed features, or altered sensorium. Medical, neurologic, endocrine, or toxicologic conditions may precipitate manic syndromes.
Clinical Features And Assessment
History should focus on recent manic symptoms, often requiring information from family or other informants. Key features include elevated, expansive, or irritable mood; increased energy and activity; reduced need for sleep; pressured speech; distractibility; racing thoughts; impulsivity; grandiosity; poor judgment; and engagement in high-risk behaviors. Past episodes of mania or depression, medication nonadherence, recent antidepressant initiation or discontinuation, substance use, and family history of bipolar disorder are critical elements. Medical history should assess for endocrine, metabolic, or neurologic disease and current or recent medications.
On examination, patients often appear hyperactive or agitated, with loud, rapid, or pressured speech. Affect is commonly irritable and labile, with intermittent tearfulness or dysphoria that may obscure diagnosis. Thought processes may be rapid, tangential, incoherent, or delirious. Thought content may include mood-congruent psychosis such as grandiose delusions or mood-incongruent psychotic features indistinguishable from other psychotic disorders. Judgment is typically impaired, with inflated self-esteem and uncharacteristic financial, sexual, or social indiscretions. Sensorium is usually intact, though confusion or delirium can occur.
Essential Evaluation
A focused physical and neurologic examination with vital signs is mandatory. Because mania can mimic delirium, a full medical evaluation may be required to exclude secondary causes.
Diagnostic Testing
Laboratory studies include toxicology screening, blood alcohol level, electrolytes, glucose, complete blood count, thyroid-stimulating hormone, and serum levels of lithium, carbamazepine, or valproate when relevant. Additional testing is guided by clinical context. Neuroimaging is reserved for suspected neurologic pathology.
Differential Diagnosis
Consider primary mania, schizoaffective disorder, psychotic disorders, agitated depression, personality disorders, attention-deficit disorder, conduct or impulse-control disorders, intoxication or withdrawal from alcohol or sedative-hypnotics, stimulant intoxication, medication-induced states including antidepressants, corticosteroids, thyroid hormone, anticholinergics, and antiparkinsonian agents, as well as metabolic, endocrine, infectious, inflammatory, vascular, neoplastic, and postictal neurologic conditions.
Initial Management And Safety Measures
Patients with mania carry a high risk of violence and impulsivity. Management begins with a calm, nonconfrontational approach in a low-stimulation environment, with adequate security support. Physical restraints and sedation may be required. Cooperative but agitated patients may be treated with oral antipsychotics or benzodiazepines. Uncooperative or severely agitated patients are commonly managed with combined haloperidol and lorazepam administered orally, intramuscularly, or intravenously, though monotherapy with either class may be appropriate. Alternative parenteral agents include lorazepam, olanzapine, ziprasidone, or chlorpromazine, with dose reductions in elderly or frail patients.
Emergency Department Treatment Strategies
Outpatient management may include short-term antipsychotics for symptom control, sleep-promoting agents, discontinuation of antidepressants if implicated, and initiation or resumption of mood stabilizers, recognizing that therapeutic effects may take days to weeks. Inpatient care is indicated for severe agitation, psychosis, unsafe behavior, or medical instability, with sedation and mood stabilizer initiation coordinated with psychiatry.
Pharmacologic Options
Acute agitation may be treated with lorazepam 2 mg orally or intramuscularly, repeatable as needed, or haloperidol 5 mg orally with similar repetition limits. Combination therapy using haloperidol 5 mg with lorazepam 1–2 mg is commonly effective. Parenteral alternatives include olanzapine, ziprasidone, aripiprazole, or chlorpromazine, with attention to hypotension and QT prolongation risks. Maintenance and outpatient medications include lithium, valproate, carbamazepine, lamotrigine, and atypical antipsychotics such as quetiapine, risperidone, olanzapine, and aripiprazole, often combined with benzodiazepines. Lamotrigine requires strict gradual titration to minimize risk of severe dermatologic reactions, particularly after interruptions. Pregnancy significantly complicates management, as lithium, valproate, and carbamazepine carry substantial teratogenic risk, especially early in gestation.
Disposition And Follow-Up
Involuntary hospitalization is required when patients pose a danger to themselves or others, exhibit severe impairment in self-care, display unsafe behaviors due to impaired judgment, or require diagnostic clarification. Patients with mild symptoms may be discharged if safety supports are in place, treatment adherence is likely, and prompt outpatient psychiatric follow-up within one to three days is arranged. Some patients may decline treatment despite not meeting criteria for involuntary commitment; education regarding future care options should be provided to patients and families.
Key Clinical Insights And Common Errors
Mania often presents with irritability or dysphoria rather than euphoria. Patients presenting with depression should always be screened for past or current manic or hypomanic symptoms, as misdiagnosis is common. Comorbid substance use is frequent and complicates management. Early identification of prodromal manic symptoms may prevent full episodes. In children, bipolar disorder frequently manifests as behavioral disinhibition or persistent irritability rather than classic mood elevation.
Core Concepts And Definitions
Mania has a broad and often subtle presentation that may be difficult to recognize in the emergency setting. Manifestations range from irritability or cheerfulness to agitation, delirium, or frank psychosis, with the full extent of illness often revealed only through collateral history. Onset may be gradual or abrupt, with episodes typically lasting weeks to months and only rarely becoming chronic. Hypomania represents a milder form without marked functional impairment. Mixed mood states involve concurrent manic and depressive features and should be managed as mania in the emergency department. Bipolar disorder, formerly termed manic-depressive illness, is defined by one or more episodes of hypomania, mania, or mixed mood, often accompanied by depressive episodes. Bipolar II disorder refers to patients who experience hypomania but never full mania. The illness commonly begins in adolescence or early adulthood, with episodes varying widely in severity, duration, and frequency. Treatment responsiveness ranges from excellent to highly refractory. Schizoaffective disorder is characterized by mood episodes accompanied by psychotic symptoms that persist even during euthymic periods.
Etiologic Considerations
Bipolar disorder is most often a primary psychiatric illness with a strong genetic association. Secondary causes must be considered, particularly in patients over 40 years of age presenting with a first episode, atypical or mixed features, or altered sensorium. Medical, neurologic, endocrine, or toxicologic conditions may precipitate manic syndromes.
Clinical Features And Assessment
History should focus on recent manic symptoms, often requiring information from family or other informants. Key features include elevated, expansive, or irritable mood; increased energy and activity; reduced need for sleep; pressured speech; distractibility; racing thoughts; impulsivity; grandiosity; poor judgment; and engagement in high-risk behaviors. Past episodes of mania or depression, medication nonadherence, recent antidepressant initiation or discontinuation, substance use, and family history of bipolar disorder are critical elements. Medical history should assess for endocrine, metabolic, or neurologic disease and current or recent medications.
On examination, patients often appear hyperactive or agitated, with loud, rapid, or pressured speech. Affect is commonly irritable and labile, with intermittent tearfulness or dysphoria that may obscure diagnosis. Thought processes may be rapid, tangential, incoherent, or delirious. Thought content may include mood-congruent psychosis such as grandiose delusions or mood-incongruent psychotic features indistinguishable from other psychotic disorders. Judgment is typically impaired, with inflated self-esteem and uncharacteristic financial, sexual, or social indiscretions. Sensorium is usually intact, though confusion or delirium can occur.
Essential Evaluation
A focused physical and neurologic examination with vital signs is mandatory. Because mania can mimic delirium, a full medical evaluation may be required to exclude secondary causes.
Diagnostic Testing
Laboratory studies include toxicology screening, blood alcohol level, electrolytes, glucose, complete blood count, thyroid-stimulating hormone, and serum levels of lithium, carbamazepine, or valproate when relevant. Additional testing is guided by clinical context. Neuroimaging is reserved for suspected neurologic pathology.
Differential Diagnosis
Consider primary mania, schizoaffective disorder, psychotic disorders, agitated depression, personality disorders, attention-deficit disorder, conduct or impulse-control disorders, intoxication or withdrawal from alcohol or sedative-hypnotics, stimulant intoxication, medication-induced states including antidepressants, corticosteroids, thyroid hormone, anticholinergics, and antiparkinsonian agents, as well as metabolic, endocrine, infectious, inflammatory, vascular, neoplastic, and postictal neurologic conditions.
Initial Management And Safety Measures
Patients with mania carry a high risk of violence and impulsivity. Management begins with a calm, nonconfrontational approach in a low-stimulation environment, with adequate security support. Physical restraints and sedation may be required. Cooperative but agitated patients may be treated with oral antipsychotics or benzodiazepines. Uncooperative or severely agitated patients are commonly managed with combined haloperidol and lorazepam administered orally, intramuscularly, or intravenously, though monotherapy with either class may be appropriate. Alternative parenteral agents include lorazepam, olanzapine, ziprasidone, or chlorpromazine, with dose reductions in elderly or frail patients.
Emergency Department Treatment Strategies
Outpatient management may include short-term antipsychotics for symptom control, sleep-promoting agents, discontinuation of antidepressants if implicated, and initiation or resumption of mood stabilizers, recognizing that therapeutic effects may take days to weeks. Inpatient care is indicated for severe agitation, psychosis, unsafe behavior, or medical instability, with sedation and mood stabilizer initiation coordinated with psychiatry.
Pharmacologic Options
Acute agitation may be treated with lorazepam 2 mg orally or intramuscularly, repeatable as needed, or haloperidol 5 mg orally with similar repetition limits. Combination therapy using haloperidol 5 mg with lorazepam 1–2 mg is commonly effective. Parenteral alternatives include olanzapine, ziprasidone, aripiprazole, or chlorpromazine, with attention to hypotension and QT prolongation risks. Maintenance and outpatient medications include lithium, valproate, carbamazepine, lamotrigine, and atypical antipsychotics such as quetiapine, risperidone, olanzapine, and aripiprazole, often combined with benzodiazepines. Lamotrigine requires strict gradual titration to minimize risk of severe dermatologic reactions, particularly after interruptions. Pregnancy significantly complicates management, as lithium, valproate, and carbamazepine carry substantial teratogenic risk, especially early in gestation.
Disposition And Follow-Up
Involuntary hospitalization is required when patients pose a danger to themselves or others, exhibit severe impairment in self-care, display unsafe behaviors due to impaired judgment, or require diagnostic clarification. Patients with mild symptoms may be discharged if safety supports are in place, treatment adherence is likely, and prompt outpatient psychiatric follow-up within one to three days is arranged. Some patients may decline treatment despite not meeting criteria for involuntary commitment; education regarding future care options should be provided to patients and families.
Key Clinical Insights And Common Errors
Mania often presents with irritability or dysphoria rather than euphoria. Patients presenting with depression should always be screened for past or current manic or hypomanic symptoms, as misdiagnosis is common. Comorbid substance use is frequent and complicates management. Early identification of prodromal manic symptoms may prevent full episodes. In children, bipolar disorder frequently manifests as behavioral disinhibition or persistent irritability rather than classic mood elevation.
0 Comments
